Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-002479
Filing Date
2025-04-02
Accepted
2025-04-02 21:01:08
Documents
1
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 13287
  Complete submission text file 0001641172-25-002479.txt   16343
Mailing Address 2601 INSLAND PLACE TOWER 510 KINGS RD N POINT HONG KONG K3 999999999
Business Address
Chan Heng Fai Ambrose (Reporting) CIK: 0001261725 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42212 | Film No.: 25807186

Mailing Address 10 WINSTEDT ROAD #02-02 SINGAPORE U0 227977
Business Address 10 WINSTEDT ROAD #02-02 SINGAPORE U0 227977 65 633391181
Alset International Ltd (Reporting) CIK: 0001660984 (see all company filings)

State of Incorp.: U0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-42212 | Film No.: 25807185

Mailing Address 4800 MONTGOMERY LANE SUITE 210 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 210 BETHESDA MD 20814 3019713955
Alset Inc. (Reporting) CIK: 0001750106 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-42212 | Film No.: 25807184
SIC: 6500 Real Estate
(CF Office: 05 Real Estate & Construction)

Mailing Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084
Business Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084 585 232 1500
IMPACT BIOMEDICAL INC. (Issuer) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)